Biolife Solutions (BLFS) Receivables (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Receivables data on file, last reported at $13.1 million in Q1 2026.

• Receivables for Q1 2026 came in at $13.1 million, up 42.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.1 million (up 42.43% YoY), and the FY2025 annual result was $8.0 million, down 6.17% from the prior year.
• Receivables grew to $13.1 million in Q1 2026 per BLFS's latest filing, from $8.0 million in the prior quarter.
• Over five years, Receivables peaked at $33.9 million in Q4 2022 and troughed at $7.9 million in Q4 2023.
• A 5-year average of $19.2 million and a median of $18.1 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2023: Receivables surged 127.49% in 2022, then sank 76.73% in 2023.
• A 5-year view of Receivables shows it stood at $33.9 million in 2022, then slumped by 76.73% to $7.9 million in 2023, then grew by 7.32% to $8.5 million in 2024, then slipped by 6.17% to $8.0 million in 2025, then surged by 64.18% to $13.1 million in 2026.
• Business Quant data shows BLFS's Receivables at $13.1 million in Q1 2026, $8.0 million in Q4 2025, and $10.8 million in Q3 2025.